Xellera Therapeutics is a CDMO focused on Cell and Gene Therapy (CGT) and Advanced Therapy Products (ATP), providing GMP-compliant manufacturing solutions that streamline development and accelerate the path to commercialization.
Search
Recent Updates
More Stories
Sponsored